Summary of a Public FDA Workshop: Model Informed Drug Development Approaches for Immunogenicity Assessments.
Artur A BelovMarisabel Rodriguez MessanOsman N YogurtcuKimberly SchultzKimberly MaxfieldLaura ThompsonSherri RevellYolonda Warren-HendersonMillion A TegengeZuben E SaunaRichard A ForsheePublished in: Clinical pharmacology and therapeutics (2022)